# Experiences of stigma and discrimination among people experiencing homelessness: a cross-sectional pilot survey in South London, UK

**Authors:** Andy Guise, Martin McCusker, Jude Adams, River Újhadbor, Simone Helleren, Tuba Mazhari, Lotte Elton, Sujit D Rathod, Lucy Platt

PMC · DOI: 10.1136/bmjopen-2025-103529 · BMJ Open · 2025-10-20

## TL;DR

This study explores how people without homes in South London face unfair treatment in various settings like public areas, legal systems, and healthcare.

## Contribution

The study provides new insights into the widespread nature of stigma and discrimination experienced by homeless individuals across multiple systems.

## Key findings

- 85% of participants reported unfair treatment in public settings.
- People with more health issues faced more unfair treatment across multiple systems.
- Homelessness was the most commonly cited reason for discrimination.

## Abstract

To understand experiences of stigma and discrimination among adults who are homeless across multiple care and support system contexts.

Cross-sectional survey embedded within an ethnographic case study.

South London, UK, 2024.

Convenience sample of 74 people experiencing homelessness, aged over 18 years.

Participants most commonly reported unfair treatment in public settings (85%), legal settings (72%), housing and homelessness services (68%) and health settings (65%). These experiences were attributed to a range of factors and identities, with homelessness the most commonly cited; people commonly linked unfair experiences to multiple identities. People with more comorbidities reported experiencing unfair treatment across more system settings, including and beyond health systems.

Unfair treatment was reported across multiple care and support systems with greater ill-health associated with more unfair treatment. Future larger-scale surveys should measure the extent of stigma and discrimination across the population.

## Full-text entities

- **Diseases:** infectious disease (MESH:D003141), TB (MESH:D014390), attention deficit hyperactivity disorder (MESH:D001289), tuberculosis (MESH:D014376), asthma (MESH:D001249), drug (MESH:D000081015), vision impairment (MESH:D014786), breathing problems (MESH:D004417), high blood pressure (MESH:D006973), health (OMIM:603663), learning difficulty (MESH:D007859), drug overdose (MESH:D062787), autism (MESH:D001321), discrimination (MESH:D010468), depression (MESH:D003866), diabetes (MESH:D003920), psychosis (MESH:D011618), COPD (MESH:D029424), dyslexia (MESH:D004410), cardiovascular disease (MESH:D002318), bipolar (MESH:D001714), traumas (MESH:D014947)
- **Chemicals:** alcohol (MESH:D000438)
- **Species:** hepatitis C virus [taxon 11103], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12542552/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12542552/full.md

---
Source: https://tomesphere.com/paper/PMC12542552